av/transgene--big.svg

    FR:TRANSGENE

    Transgene

    • Stock

    0.66

    −0.90%

    −0.01

    EUR last updated 01/04 01:29:30

    Last Close

    0.67

    31/03 15:35

    Market Cap

    106.75M

    Beta: -

    Volume Today

    54.28K

    Avg: -

    Description

    Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. It is involved in developing TG4050, a therapeutic vaccine that is in phase I clinical trial for the treatment of ovarian cancer, and human papilloma virus (HPV)-negative head and neck cancers; TG4001, a thera...Show More

    peer of

    competitor of